Sleeping pill market making comeback

04/19/2005 | Wall Street Journal, The

The market in sleeping pills, which took a nosedive after problems were reported with Halcion more than 10 years ago, appears to be experiencing a comeback, thanks in part to Sanofi-Aventis' drug Ambien. Now Sepracor is entering the market with Lunesta, which already has experienced strong demand, and three more sleeping pill applications are pending at the FDA.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Fort Worth, TX
Director, Senior Legal Counsel
Fort Worth, TX